Mona Katrine Alberthe Holm
Overview
Explore the profile of Mona Katrine Alberthe Holm including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jansaker F, Holm M, Knudsen J, Boel J
Heliyon
. 2024 Jul;
10(13):e33696.
PMID: 39040231
Objectives: Bacteremia is an acute severe infection with high mortality. Changes in healthcare services and coinfections with SARS-CoV-2 may have affected the mortality for bacteremia during the COVID-19 pandemic, which...
2.
Bartels M, Holm M, Worning P, Stavad B, Schneider U, Meiniche H, et al.
APMIS
. 2023 Apr;
131(6):294-302.
PMID: 37026991
Whole genome sequencing (WGS) has greatly improved the detection of methicillin-resistant Staphylococcus aureus (MRSA) transmission between people. We describe the transmission of two unique MRSA clones among homeless people in...
3.
Rubin I, Mollerup S, Broholm C, Baker A, Holm M, Pedersen M, et al.
Appl Environ Microbiol
. 2022 Sep;
88(19):e0108722.
PMID: 36165644
Synbiotics combine probiotics and prebiotics and are being investigated for potential health benefits. In this single-group-design trial, we analyzed changes in the gut microbiome, stool quality, and gastrointestinal well-being in...
4.
Holm M, Jorgensen K, Bagge K, Worning P, Pedersen M, Westh H, et al.
Microbiol Spectr
. 2022 Aug;
10(5):e0129622.
PMID: 36000891
Methicillin-resistant Staphylococcus aureus (MRSA) is a common bacterial pathogen that frequently colonizes healthy individuals, with potential to cause invasive infection. In Denmark, to keep the prevalence low, MRSA carriers are...
5.
Holm M, Meiniche H, Pedersen M, Eriksen H, Westh H, Holzknecht B, et al.
Trials
. 2022 Jun;
23(1):502.
PMID: 35710440
Background: Staphylococcus aureus is a frequent colonizer of the human skin and mucous membranes but can also cause a variety of serious infections. Antimicrobial resistance is an increasing worldwide challenge...
6.
Rubin I, Mollerup S, Broholm C, Knudsen S, Baker A, Helms M, et al.
Microbiol Spectr
. 2022 Apr;
10(3):e0234821.
PMID: 35475684
The purpose of this trial was to evaluate the efficacy of a 4-week supplementation of Lactobacillus rhamnosus GG (LGG) in eliminating the gastrointestinal carrier state of vancomycin-resistant Enterococcus faecium (VREfm)...
7.
Holm M, Jansaker F, Gradel K, Thoft Nielsen R, Andersen C, Jarlov J, et al.
Int J Environ Res Public Health
. 2021 Jul;
18(11).
PMID: 34199587
Introduction: Bacteraemia is a frequent infectious condition that strongly affects morbidity and mortality. The incidence is increasing worldwide. This study explores all-cause 30-day mortality after bacteraemia in two out of...
8.
Holm M, Nordmann Winther T, Kammann S, Rasmusson M, Brooks L, Westh H, et al.
PLoS One
. 2021 Jan;
16(1):e0246343.
PMID: 33513178
Background: Methicillin resistant Staphylococcus aureus (MRSA) frequently causes outbreaks in neonatal intensive care units (NICUs). It is believed that MRSA predominantly enters the NICU with MRSA colonized parents. In Denmark,...
9.
Schneider U, Holm M, Bang D, Petersen R, Mortensen S, Trebbien R, et al.
Euro Surveill
. 2020 Nov;
25(44).
PMID: 33153518
BackgroundPoint-of-care tests (POCT) for influenza A and B viruses and respiratory syncytial virus (RSV) were implemented in emergency departments of all hospitals in the Capital Region of Denmark in 2018.AimTo...
10.
Jansaker F, Holm M, Gradel K, Knudsen J, Boel J
Clin Infect Dis
. 2020 Sep;
73(7):e1758-e1761.
PMID: 32918453
This study explored all-cause mortality of bacteremia diagnosed during a 60-day non-physician healthcare worker strike in 2008. A significant change, with 5.0% (95% confidence interval [CI] 1.2-8.7%, P < .01)...